Now is the time for employers to take the next step forward in supporting employees and their dependent children on the path to securing the health and future of their workforce.

The pharmaceutical company is pushing for fast-track FDA approval of its diabetes drug Mounjaro for obesity today, after releasing promising clinical trial data that validates its claims for weight loss.

"The disruption and fragmentation that have characterized health care over the past year are clearly reflected in the perspectives of both consumers and plan sponsors," the study concludes

Only 2.5% of DC plan participants stopped contributing to their plans last year, indicating disciplined savings habits through stretches of inflation, market volatility and lingering concerns of a recession, according to a new study.